[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in the province of Alicante]. / Fingolimod: efectividad y seguridad en la practica clinica habitual. Estudio observacional, retrospectivo y multicentrico en la provincia de Alicante.

INTRODUCTION: Post-authorisation studies are important to confirm whether the outcomes of clinical trials are reproduced in usual clinical practice. AIMS: To evaluate the effectiveness and safety of fingolimod in clinical practice in the province of Alicante. PATIENTS AND METHODS: A retrospective multi-centre study was conducted with remitting multiple sclerosis patients treated with fingolimod. Demographic, clinical and pharmacological data were collected. We report on the effectiveness of the drug -annualised relapse rate (ARR) and percentage of patients free from attacks- at one and at two years after treatment in relation to the previous year, and data concerning side effects are also provided. RESULTS: The sample consisted of 89 patients. Previous treatment was with immunomodulators (interferon beta or glatiramer acetate) in 54 patients and natalizumab in 32. Fifty patients changed due to failure with the immunomodulator and 31 owing to positive serology for JC virus (JCV+). Overall ARR decreased by 67.3% the first year (p < 0.0001) and by 84.1% the second (p = 0.0078). It diminished in patients with immunomodulator failure (85.6% the first year, p < 0.0001; 88.9% the second year, p = 0.0039) and increased in a non-significant manner in JCV+ patients in the first year. The percentage of patients free from relapses in the overall population increased from 32.6% to 68.1% in the first year (p < 0.0019) and to 82.6% in the second (p = 0.0215). This increase was not observed in JCV+ patients. Side effects were reported by 13 patients, which led to the drug being withdrawn in two of them. CONCLUSION: In clinical practice in the province of Alicante, levels of effectiveness and safety of fingolimod proved to be slightly higher than those found in clinical trials.

TITLE: Fingolimod: efectividad y seguridad en la practica clinica habitual. Estudio observacional, retrospectivo y multicentrico en la provincia de Alicante.Introduccion. Los estudios postautorizacion son importantes para confirmar si los resultados de los ensayos clinicos se reproducen en la practica clinica habitual. Objetivo. Evaluar la efectividad y seguridad del fingolimod en la practica clinica en la provincia de Alicante. Pacientes y metodos. Estudio multicentrico retrospectivo de pacientes con esclerosis multiple remitente tratados con fingolimod. Se recogen las caracteristicas demograficas, clinicas y farmacologicas. Se describe la efectividad del farmaco ­tasa anualizada de brotes (TAB) y porcentaje de pacientes libres de brotes­ al año y a los dos años de tratamiento en relacion con el año previo y datos de efectos secundarios. Resultados. Se incluyo a 89 pacientes. El tratamiento previo fue inmunomodulador (interferon beta o acetato de glatiramero) en 54 pacientes y natalizumab en 32. Cincuenta pacientes cambiaron por fracaso con el inmunomodulador y 31 por serologia positiva del virus JC (VJC+). La TAB global disminuyo el 67,3% el primer año (p < 0,0001) y el 84,1% el segundo (p = 0,0078). Disminuyo en los pacientes con fracaso del inmunomodulador (el 85,6% el primer año, p < 0,0001; el 88,9% el segundo año, p = 0,0039) y aumento de forma no significativa en los pacientes VJC+ en el primer año. El porcentaje de pacientes libres de brotes en la poblacion global aumento del 32,6 al 68,1% en el primer año (p < 0,0019) y al 82,6% en el segundo (p = 0,0215). Este aumento no se observo en los pacientes VJC+. Trece pacientes tuvieron efectos secundarios, que obligaron a la retirada del farmaco en dos de ellos. Conclusion. En la practica clinica de la provincia de Alicante, el fingolimod mostro una efectividad y una seguridad ligeramente superiores a las de los ensayos clinicos.

[Rendu-Osler-Weber disease as an infrequent cause of stroke]. / Enfermedad de Rendu-Osler-Weber como causa infrecuente de ictus.

INTRODUCTION: Hereditary haemorrhagic telangiectasia, or Rendu-Osler disease, is a congenital vascular disease that is associated with the presence of arteriovenous fistulas that cause paradoxical embolisms. CASE REPORT: An 83-year-old female with clinical signs and symptoms of convulsive attacks and multiple cerebral infarctions in the acute phase. She also presented a history of multiple haemorrhages and iron deficiency anaemia with no clear aetiological causation. A thorough examination of her medical history revealed a family history of haemorrhages and a sister who had been diagnosed with Rendu-Osler disease, which suggested the possible existence of a pulmonary arteriovenous fistula as the aetiological causation of her cerebrovascular disease. Neurovascular Doppler ultrasonography with bubble contrast test was positive, and the presence of the fistula was confirmed by a computerised axial tomographic angiography scan of the lungs. CONCLUSIONS: Rendu-Osler disease is a rare cause of stroke due to the fact that it is usually associated with arteriovenous fistulas that can cause paradoxical embolisms. Neurovascular Doppler ultrasound scanning is useful for detecting these pulmonary fistulas by means of the bubble contrast test, which is a non-invasive test that can be carried out easily by neurologists themselves.

Enfermedad de Rendu-Osler-Weber como causa infrecuente de ictus / Rendu-osler-weber disease as an infrequent cause of stroke

La telangiectasia hemorrágica hereditaria o enfermedad de Rendu-Osler es una enfermedad vascularcongénita que se asocia con la presencia de fístulas arteriovenosas que son causa de embolias paradójicas. Caso clínico. Mujer de 83 años que ingresa con clínica de crisis epilépticas y múltiples infartos cerebrales en fase aguda. Asocia historiaprevia de múltiples hemorragias y anemia ferropénica sin clara causa etiológica. Tras una exhaustiva anamnesis, se descubre historia familiar de hemorragias y una hermana diagnosticada de enfermedad de Rendu-Osler-Weber, lo que sugiere la posible existencia de una fístula arteriovenosa pulmonar como causa etiológica de su enfermedad cerebrovascular. Se realiza Doppler neurovascular con infusión de test de burbujas con resultado positivo, lo cual confirma la presencia de la fístula mediante angiotomografía axial computarizada pulmonar. Conclusión. La enfermedad de Rendu-Osler es una causa poco frecuente de ictus debido a que suele asociar fístulas arteriovenosas que pueden ser causa de embolias paradójicas. El Doppler neurovascular es útil para la detección de estas fístulas pulmonares mediante el test de infusión de burbujas; se trata de unaprueba no cruenta y de fácil realización por parte de los propios neurólogos

Hereditary haemorrhagic telangiectasia, or Rendu-Osler disease, is a congenital vascular diseasethat is associated with the presence of arteriovenous fistulas that cause paradoxical embolisms. Case report. An 83-year-old female with clinical signs and symptoms of convulsive attacks and multiple cerebral infarctions in the acute phase. She also presented a history of multiple haemorrhages and iron deficiency anaemia with no clear aetiological causation. A thoroughexamination of her medical history revealed a family history of haemorrhages and a sister who had been diagnosed with Rendu-Osler disease, which suggested the possible existence of a pulmonary arteriovenous fistula as the aetiological causation of her cerebrovascular disease. Neurovascular Doppler ultrasonography with bubble contrast test was positive, and the presence of the fistula was confirmed by a computerised axial tomographic angiography scan of the lungs. Conclusions. Rendu-Osler disease is a rare cause of stroke due to the fact that it is usually associated with arteriovenous fistulas that can cause paradoxical embolisms. Neurovascular Doppler ultrasound scanning is useful for detecting these pulmonary fistulas by means of the bubble contrast test, which is a non-invasive test that can be carried out easily by neurologists themselves

[An analysis of avoidable admissions to a neurology service]. / Análisis de los ingresos evitables en un servicio de neurología.

INTRODUCTION: Inappropriate admissions to a hospital service generate unnecessary costs for our health care service. Most admissions to a hospital service come from the emergency department. The presence of a neurologist to attend hospital emergencies would be an important factor allowing admission criteria to be streamlined. AIMS: To determine the number of avoidable admissions (AA) in a neurology service, and to define their characteristics. PATIENTS AND METHODS: We conducted a prospective, descriptive study of the admissions that took place in the Neurology Service of the Hospital General Universitario de Elche (Alicante) over a period of three months. The neurologist determines whether admission is indicated or not. We collected demographic data concerning the patient, the admission diagnosis, neurological diagnosis, the reason for appropriateness and the reason for AA. RESULTS: A total of 250 admissions were attended; 65 were considered to be AA (26%). The most frequent diagnoses in the cases of AA were non-neurological (32.3%), clinical findings (15.4%), neuropathies (10.8%) and epilepsy (10.8%). The reasons leading to AA were non-neurological and transfer to another service (30.8%), follow-up by neurology outpatient department (NOD) (29.2%), NOD study (21.5%), non-neurological and discharge (16.9%) and not specified (1.5%). The mean length of stay in the case of AA was 4.3 days. CONCLUSIONS: The number of AA in our service is higher than that found in other studies. On-duty neurologists, streamlining outpatient diagnostic testing and the design of flexible schedules for outpatient care would reduce the amount of resources that are used, while at the same time increasing the quality of the health service.

Análisis de los ingresos evitables en un servicio de neurología / An analysis of avoidable admissions to a neurology service

Introducción. Los ingresos inadecuados a un servicio hospitalariogeneran costes innecesarios a nuestro sistema de salud.La mayoría de ingresos en un servicio hospitalario procede delárea de urgencias. La presencia de un neurólogo que atienda lasurgencias hospitalarias constituiría un factor importante pararacionalizar los criterios de hospitalización. Objetivos. Determinarel número de ingresos evitables (IE) en un servicio de neurologíaasí como definir las características de éstos. Pacientes y métodos.Estudio descriptivo prospectivo de los ingresos realizados enel Servicio de Neurología del Hospital General Universitario deElche (Alicante) durante tres meses. El neurólogo determina laindicación de ingreso. Se recogen los datos de filiación del paciente,el diagnóstico del ingreso, el diagnóstico del neurólogo, el motivode adecuación y el motivo de IE. Resultados. Se atendieron untotal de 250 ingresos; 65 se consideraron IE (26%). Los diagnósticosmás frecuentes de los IE fueron: no neurológico (32,3%), síntomasy signos (15,4%), neuropatías (10,8%) y epilepsia (10,8%).Los motivos de IE fueron: no neurológico y traslado de servicio(30,8%), seguimiento en consultas externas de neurología (CEN)(29,2%), estudio en CEN (21,5%), no neurológico y alta (16,9%) yno consta (1,5%). Los IE tuvieron una estancia media de 4,3 días.Conclusiones. El número de IE en nuestro servicio es más elevadoque en otros estudios. La disponibilidad de guardias de neurología,la agilización de la realización ambulatoria de pruebasdiagnósticas y el diseño de agendas flexibles de asistencia ambulatoriasupondrían una reducción en la utilización de recursos, yaumentaría la calidad del servicio asistencial

Introduction. Inappropriate admissions to a hospital service generate unnecessary costs for our health care service.Most admissions to a hospital service come from the emergency department. The presence of a neurologist to attend hospitalemergencies would be an important factor allowing admission criteria to be streamlined. Aims. To determine the number ofavoidable admissions (AA) in a neurology service, and to define their characteristics. Patients and methods. We conducted aprospective, descriptive study of the admissions that took place in the Neurology Service of the Hospital General Universitariode Elche (Alicante) over a period of three months. The neurologist determines whether admission is indicated or not. Wecollected demographic data concerning the patient, the admission diagnosis, neurological diagnosis, the reason for appropriatenessand the reason for AA. Results. A total of 250 admissions were attended; 65 were considered to be AA (26%). The mostfrequent diagnoses in the cases of AA were non-neurological (32.3%), clinical findings (15.4%), neuropathies (10.8%) andepilepsy (10.8%). The reasons leading to AA were non-neurological and transfer to another service (30.8%), follow-up byneurology outpatient department (NOD) (29.2%), NOD study (21.5%), non-neurological and discharge (16.9%) and notspecified (1.5%). The mean length of stay in the case of AA was 4.3 days. Conclusions. The number of AA in our service ishigher than that found in other studies. On-duty neurologists, streamlining outpatient diagnostic testing and the design offlexible schedules for outpatient care would reduce the amount of resources that are used, while at the same time increasingthe quality of the health service